ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,872.99
0.17%
Gold vs US Dollar
2,414.865
-0.27%
Brent Oil
82.205
-0.29%
Bitcoin
69,852.90
-0.40%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Glucose Health Inc (PK) (GLUC)

  7. Glucose Health Inc (PK) (GLUC) News

Glucose Health (PK) (GLUC)

Glucose Health Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:GLUC
DateTimeSourceHeadlineSymbolCompany
07/12/202319:58Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:GLUCGlucose Health Inc (PK)
28/06/202318:23Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:GLUCGlucose Health Inc (PK)
28/06/202318:23Edgar (US Regulatory)Form RW - Registration Withdrawal RequestUSOTC:GLUCGlucose Health Inc (PK)
23/03/202319:23InvestorsHub NewsWireGlucose Health, Inc. Fiscal 2022 Annual ReportUSOTC:GLUCGlucose Health Inc (PK)
03/11/202211:06InvestorsHub NewsWireIMPORTANT CORPORATE DEVELOPMENTS - GLUCOSE HEALTH, INC. (OTC: GLUC)USOTC:GLUCGlucose Health Inc (PK)
24/10/202212:10InvestorsHub NewsWireGlucose Health, Inc. (OTC: GLUC) Quarterly Report - Q3 Fiscal 2022USOTC:GLUCGlucose Health Inc (PK)
06/09/202211:03Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:GLUCGlucose Health Inc (PK)
01/06/202211:06Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:GLUCGlucose Health Inc (PK)
24/03/202211:35InvestorsHub NewsWireGlucose Health, Inc. Corporate UpdateUSOTC:GLUCGlucose Health Inc (PK)
17/03/202219:00InvestorsHub NewsWireGlucose Health, Inc. Corporate UpdateUSOTC:GLUCGlucose Health Inc (PK)
10/02/202213:00InvestorsHub NewsWireGlucose Health, Inc. Fiscal 2021 Annual ReportUSOTC:GLUCGlucose Health Inc (PK)
28/12/202113:00InvestorsHub NewsWireGlucose Health, Inc. USPTO Patent Filing Asserts First Use of Nutritional Composition Underlying GLUCODOWN®USOTC:GLUCGlucose Health Inc (PK)
03/11/202119:30InvestorsHub NewsWireGlucose Health, Inc. Fiscal 2021 Revenue Up 110% For Nine Month Period Ended September 30, 2021USOTC:GLUCGlucose Health Inc (PK)
07/09/202112:15InvestorsHub NewsWireNEW GLUCODOWN "ENHANCED WATER" BEVERAGES LAUNCH TODAY AT AMAZON -- SPECIAL LOYALTY DISCOUNT IN EFFECT UNTIL FRIDAYUSOTC:GLUCGlucose Health Inc (PK)
24/08/202118:05InvestorsHub NewsWireGlucose Health, Inc. Fiscal 2021 6-Month Update; Zero Debt, Zero Liabilities, Fully Diluted Share Count Reduced by 1/3.USOTC:GLUCGlucose Health Inc (PK)
09/08/202111:30InvestorsHub NewsWireGlucose Health, Inc. Reports Fiscal 2021 YTD Revenue Up 123% and New Amazon Sales RecordUSOTC:GLUCGlucose Health Inc (PK)
26/05/202111:00InvestorsHub NewsWireGlucose Health, Inc. Surpasses 2020 Sales at AmazonUSOTC:GLUCGlucose Health Inc (PK)
17/05/202111:00InvestorsHub NewsWireGlucose Health, Inc. Reports Q1 Fiscal 2021 Revenue Increases 187%USOTC:GLUCGlucose Health Inc (PK)
21/04/202112:00InvestorsHub NewsWireGlucose Health, Inc. Reports March Revenue Triples at Amazon and Announces Major Expansion of TV-Digital Advertising StrategyUSOTC:GLUCGlucose Health Inc (PK)
31/03/202113:00InvestorsHub NewsWireGlucose Health, Inc. -- Fiscal 2020 Annual Report & Q1 2021 Revenue GuidanceUSOTC:GLUCGlucose Health Inc (PK)
09/03/202112:30InvestorsHub NewsWireWatch Glucose Health, Inc. on CNBC's Shark Tank Ad Rotation Week of March 15thUSOTC:GLUCGlucose Health Inc (PK)
01/03/202113:00InvestorsHub NewsWireGlucose Health, Inc. - Amazon Revenues Exceed $50,000 Per MonthUSOTC:GLUCGlucose Health Inc (PK)
17/02/202112:30InvestorsHub NewsWireGlucose Health Inc. Ticker GLUC leads the red hot functional beverage sectorUSOTC:GLUCGlucose Health Inc (PK)
03/02/202113:00InvestorsHub NewsWireLittle known public companies that in 2020 outperformed giants such as Facebook, Google, Bitcoin, and even TeslaUSOTC:GLUCGlucose Health Inc (PK)
25/01/202112:43InvestorsHub NewsWireGlucose Health, Inc. - New 2-Pack GLUCODOWN® Raspberry # 1 at AmazonUSOTC:GLUCGlucose Health Inc (PK)
04/01/202112:30InvestorsHub NewsWireGLUCODOWN® KICKS-OFF 2021 WITH RECORD NEW YEAR'S DAY SALES AT AMAZONUSOTC:GLUCGlucose Health Inc (PK)
23/11/202012:30InvestorsHub NewsWireGLUCODOWN® DRINK MIXES COMPLETE PRODUCTION TRIAL; NEW GLUCODOWN® WEBSITE UNVEILED; YTD GROSS PROFIT MARGIN DOUBLESUSOTC:GLUCGlucose Health Inc (PK)
09/11/202012:30InvestorsHub NewsWireGLUCOSE HEALTH, INC. FISCAL 2020 3rd QUARTER REVENUE INCREASES 91% BEATING PRELIMINARY ESTIMATE BY 11%USOTC:GLUCGlucose Health Inc (PK)
13/10/202012:00InvestorsHub NewsWireGLUCODOWN® EXPANDING TO 2000 WALMART PHARMACIES FOR 2021USOTC:GLUCGlucose Health Inc (PK)
01/10/202011:45InvestorsHub NewsWireGLUCOSE HEALTH, INC. 3rd QUARTER 2020 PRELIMINARY RESULTS INDICATE 80% REVENUE INCREASEUSOTC:GLUCGlucose Health Inc (PK)
 Showing the most relevant articles for your search:USOTC:GLUC

Your Recent History

LSE
PET
Petrel Resources
LSE
QBT
Quantum Blockchain Techn...
LSE
GGP
Greatland Gold
LSE
BIRD
Blackbird
LSE
AVCT
Avacta
LSE
HMI
Harvest Minerals
LSE
PXC
Phoenix Copper
LSE
TYM
Tertiary Minerals
LSE
ITV
Itv
LSE
TERN
Tern
LSE
SOLG
Solgold
LSE
AAU
Ariana Resources
LSE
GSCU
Great Southern Copper
LSE
LLOY
Lloyds Banking
LSE
POLX
Polarean Imaging
LSE
RIO
Rio Tinto
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved